Safety & Efficacy of House Dust Mite Allergen Extract in the Treatment of

See also
Status	Clinical Trial	Phase
Completed	`NCT02443805` - Efficacy & Safety of STG320 Sublingual Tablets of HDM Allergen Extracts in Adults and Adolescents With HDM-associated AR	Phase 3
Completed	`NCT03094845` - Safety and Clinical Tolerability of hdmASIT+TM Peptides Administered in HDM-induced Allergic Patients	Phase 2
Completed	`NCT01930461` - Dose Ranging Study of SLIT Tablets of House Dust Mite Allergen Extracts (HDM) in Adults With HDM-associated Allergic Asthma	Phase 2
Completed	`NCT01923792` - ToleroMune House Dust Mite Follow on Study	N/A
Completed	`NCT00574704` - A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis	Phase 2
Completed	`NCT05019209` - Skin Responses and T Cell Immunology After House Dust Mite Exposure in Sensitized Atopic Dermatitis Patients	N/A
Recruiting	`NCT02238353` - AZELASTINE/FLUTICASONE (AZE/FLU) Nasal Spray on Symptom Control, Nasal Mediators and Nasal Hyperresponsiveness in Allergic Rhinitis (AR)	Phase 4
Completed	`NCT01454544` - A One Year Trial Evaluating the Safety and Efficacy of the ALK House Dust Mite Allergy Tablet	Phase 3
Terminated	`NCT01777464` - Role of the Central Nervous System in Allergic Rhinitis	N/A
Completed	`NCT00574223` - A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis	Phase 2
Completed	`NCT02345278` - SUBLIVAC FIX Mite Mixture Dose Tolerability Study	Phase 1/Phase 2
Completed	`NCT01608243` - Safety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts	Phase 1
Completed	`NCT04435678` - Diagnostic Accuracy of the MADx Multi Array Xplorer (MAX 45k) Automated Laboratory System and the MADx Allergy Explorer Version 2 (ALEX²) - IgE Multiplex Test for the Diagnosis of Pre-defined Groups of Specific High-priority Allergens	N/A
Completed	`NCT01134757` - Safety of Bronchial Allergen Challenge and Predictors for Positive Reaction.	N/A
Recruiting	`NCT05395689` - Efficacy and Safety Assessment of Beltavac® With Polymerized Extract of HDM	Phase 3
Not yet recruiting	`NCT05400811` - Efficacy and Safety Evaluation for the Treatment of HDM Induced Allergic Asthma and Rhinitis/Rhinoconjunctivitis	Phase 3
Not yet recruiting	`NCT05450289` - The Efficacy of Nigella Sativa in Children With House Dust Mite-Induced Respiratory Allergy Receiving Immunotherapy	N/A
Recruiting	`NCT05174689` - Epigenetic Regulation of Exercise Induced Asthma	N/A
Terminated	`NCT04874714` - Efficacy and Safety Evaluation for the Treatment of Asthma and Allergic Rhinitis/Rhinoconjunctivitis	Phase 3
Completed	`NCT00380926` - Fish Oil and Asthma in House Dust Mite Allergy	Phase 2/Phase 3

NCT number	NCT00263549
Study type	Interventional
Source	Allergopharma GmbH & Co. KG
Contact
Status	Completed
Phase	Phase 4
Start date	September 2002
Completion date	February 2006

Safety and Efficacy of House Dust Mite Allergen Extract in the Treatment of Allergic Rhinoconjunctivitis

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms